
Calian Group Ltd. (TSE:CGY – Free Report) – Research analysts at Desjardins issued their Q1 2026 EPS estimates for shares of Calian Group in a note issued to investors on Wednesday, November 26th. Desjardins analyst B. Poirier anticipates that the company will post earnings of $0.74 per share for the quarter. Desjardins has a “Buy” rating and a $66.00 price objective on the stock. The consensus estimate for Calian Group’s current full-year earnings is $4.95 per share. Desjardins also issued estimates for Calian Group’s Q2 2026 earnings at $0.89 EPS, Q3 2026 earnings at $0.86 EPS and Q4 2026 earnings at $1.10 EPS.
A number of other analysts also recently weighed in on CGY. Ventum Financial upped their target price on Calian Group from C$58.00 to C$62.00 and gave the company a “buy” rating in a research report on Thursday. Canaccord Genuity Group boosted their price target on Calian Group from C$60.00 to C$63.00 and gave the company a “buy” rating in a research note on Thursday. Royal Bank Of Canada increased their price objective on shares of Calian Group from C$58.00 to C$66.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, CIBC raised their target price on shares of Calian Group from C$59.00 to C$62.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Five analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of C$63.80.
Calian Group Stock Performance
Shares of TSE:CGY opened at C$54.11 on Monday. The firm has a market cap of C$614.15 million, a PE ratio of 30.74, a PEG ratio of 2.50 and a beta of 0.43. Calian Group has a 12-month low of C$37.70 and a 12-month high of C$54.35. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company’s 50 day moving average price is C$50.48 and its two-hundred day moving average price is C$48.82.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
See Also
- Five stocks we like better than Calian Group
- Breakout Stocks: What They Are and How to Identify Them
- Worried About Inflation? These 3 ETFs Offer Real Protection
- What Are Dividend Achievers? An Introduction
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- What Is WallStreetBets and What Stocks Are They Targeting?
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
